Nonprofits›Mass General Brigham Incorporated
Health Care
Mass General Brigham Incorporated
SOMERVILLE, MA
Total revenue
—
Total expenses
—
Net assets
—
Grants received
$898.5M
1,083 grants
EIN
042312909
Tax year
—
Grants received
Showing 200 of 1,083
FromAmountPurposeYear
$575K
APOE: APOE4 ACCELERATES CD8 EXHAUSTION VIA GLUCOCORTICOID SIGNALING IN ALZHEIMER'S FEMALE CARRIERS
2024
$276K
MBC: HARNESSING DIET-MICROBE INTERACTIONS TO PREVENT ALZHEIMER'S DISEASE PATHOGENESIS
2024
$229K
DO CLASSICAL COMPLEMENT ACTIVATION AND THE ROUTE OF ADMINISTRATION OF ANTI-AMYLOID ANTIBODIES CONTRIBUTE TO VASCULAR SIDE EFFECTS KNOWN AS ARIA?
2024
$201K
ROLE OF CHECKPOINT MOLECULES TIM-3 AND LAG-3 IN MICROGLIAL FUNCTION IN ALZHEIMER'S DISEASE
2024
$201K
T CELL MODULATION OF MICROGLIA TO TREAT ALZHEIMER'S DISEASE
2024
$200K
ALZHEIMER'S DISEASE RESEARCH BY SARAH ELISE HEUER, PHD ENTITLED: A2025005F
2024
$195K
TARGETING NEUROINFLAMMATION WITH NASAL ADMINISTRATION OF ANTI-CD3 MONOCLONAL ANTIBODY TO TREAT ALZHEIMER'S DISEASE
2024
$40K
Research to investigate "Transient Bioelectronic Implants for Enhancing Bone Growth following Spine Fusion"
2024
$25K
RESTRICTED TO DESIGNING HYPERTENSION PATIENT JOURNEY AND CONDUCTING IMPLEMENTATION RESEARCH
2024
$620K
Sub-grantee for various health system strengthening projects in Navajo Nation and support for Bring O2 projects in partner countries.
2023
$431K
A NEW MODEL OF MICROGLIA GENETIC PERTURBATION IN VIVO TO SCREEN ALL RISK FACTORS ASSOCIATED WITH ALZHEIMER'S DISEASE
2023
$288K
MBC: HARNESSING DIET-MICROBE INTERACTIONS TO PREVENT ALZHEIMER'S DISEASE PATHOGENESIS
2023
$288K
APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMER'S DISEASE
2023
$251K
General support for programs, operations and other charitable purposes
2023
$201K
TARGETING NEUROINFLAMMATION WITH NASAL ADMINISTRATION OF ANTI-CD3 MONOCLONAL ANTIBODY TO TREAT ALZHEIMER'S DISEASE
2023
$201K
ROLE OF CHECKPOINT MOLECULES TIM-3 AND LAG-3 IN MICROGLIAL FUNCTION IN ALZHEIMER'S DISEASE
2023
$201K
NEUROIMMUNE CONNECTOME PERTURBATIONS IN ALZHEIMER'S DISEASE
2023
$201K
TARGETING THE MICROBIOME AND INNATE IMMUNITY IN ALZHEIMER'S DISEASE
2023
$188K
COTZIAS - $50,000, FELLOWSHIP GRANT - $12,500, INFORMATION & REFERRAL - $25,000, MEDICAL RESEARCH-ADVANCED CENTERS - $100,000
2023
$150K
UNRESTRICTED GRANT TO SUPPORT ORGANIZATION'S EXEMPT PURPOSE
2023
$150K
RESEARCH TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION
2023
Funded by
$898.5M from 335 funders · 1,083 grants · 2016–2024
Mass General Brigham Incorporated &
$346.6M · 6 grants · 2017–2023
Fidelity Investments Charitable Gift Fund
$88.6M · 8 grants · 2017–2023
President and Fellows of Harvard College
$84.6M · 6 grants · 2017–2023
American Heart Association Inc
$46.1M · 10 grants · 2018–2023
Beth Israel Deaconess Medical Center
$22.5M · 7 grants · 2017–2023
Fred Hutchinson Cancer Research Center
$16.8M · 15 grants · 2017–2021
The Broad Institute Inc
$16.0M · 8 grants · 2017–2023
University Of Pittsburgh
$13.2M · 7 grants · 2017–2023
Details
EIN042312909
NTEE codeE21
Subsection03
Ruling date2010-11